[go: up one dir, main page]

AU2003298606A8 - Human polypeptides encoded by polynucleotides and methods of their use - Google Patents

Human polypeptides encoded by polynucleotides and methods of their use

Info

Publication number
AU2003298606A8
AU2003298606A8 AU2003298606A AU2003298606A AU2003298606A8 AU 2003298606 A8 AU2003298606 A8 AU 2003298606A8 AU 2003298606 A AU2003298606 A AU 2003298606A AU 2003298606 A AU2003298606 A AU 2003298606A AU 2003298606 A8 AU2003298606 A8 AU 2003298606A8
Authority
AU
Australia
Prior art keywords
polynucleotides
methods
polypeptides encoded
human polypeptides
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298606A
Other versions
AU2003298606A1 (en
Inventor
Justin G P Wong
Lewis T Williams
Kevin Hestir
Yan Wang
Srinivas Kothakota
Robert Forgan Halenbeck
Pierre Alvaro Beaurang
Haishan Lin
Kristen Pierce
Changjiang Zeng
Dirk Behrens
Thomas Linnemann
Hongbing Zhang
Ge Wu
Keting Chu
Ernestine Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Five Prime Therapeutics Inc
Original Assignee
Five Prime Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc filed Critical Five Prime Therapeutics Inc
Publication of AU2003298606A1 publication Critical patent/AU2003298606A1/en
Publication of AU2003298606A8 publication Critical patent/AU2003298606A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003298606A 2002-10-25 2003-10-24 Human polypeptides encoded by polynucleotides and methods of their use Abandoned AU2003298606A1 (en)

Applications Claiming Priority (127)

Application Number Priority Date Filing Date Title
US42161402P 2002-10-25 2002-10-25
US42106102P 2002-10-25 2002-10-25
US42155202P 2002-10-25 2002-10-25
US42108002P 2002-10-25 2002-10-25
US60/421,080 2002-10-25
US60/421,614 2002-10-25
US60/421,552 2002-10-25
US60/421,061 2002-10-25
US42217702P 2002-10-30 2002-10-30
US42217802P 2002-10-30 2002-10-30
US60/422,178 2002-10-30
US60/422,177 2002-10-30
US42643002P 2002-11-15 2002-11-15
US42691602P 2002-11-15 2002-11-15
US42638402P 2002-11-15 2002-11-15
US42635502P 2002-11-15 2002-11-15
US42639402P 2002-11-15 2002-11-15
US60/426,384 2002-11-15
US60/426,430 2002-11-15
US60/426,394 2002-11-15
US60/426,355 2002-11-15
US60/426,916 2002-11-15
US42965102P 2002-11-27 2002-11-27
US42932602P 2002-11-27 2002-11-27
US42927502P 2002-11-27 2002-11-27
US42922402P 2002-11-27 2002-11-27
US42930202P 2002-11-27 2002-11-27
US60/429,224 2002-11-27
US60/429,275 2002-11-27
US60/429,302 2002-11-27
US60/429,326 2002-11-27
US60/429,651 2002-11-27
US43065102P 2002-12-04 2002-12-04
US43066302P 2002-12-04 2002-12-04
US43064502P 2002-12-04 2002-12-04
US43066802P 2002-12-04 2002-12-04
US43065702P 2002-12-04 2002-12-04
US43068402P 2002-12-04 2002-12-04
US60/430,663 2002-12-04
US60/430,657 2002-12-04
US60/430,684 2002-12-04
US60/430,651 2002-12-04
US60/430,668 2002-12-04
US60/430,645 2002-12-04
US43093702P 2002-12-05 2002-12-05
US43096502P 2002-12-05 2002-12-05
US43145802P 2002-12-05 2002-12-05
US60/430,937 2002-12-05
US60/430,965 2002-12-05
US60/431,458 2002-12-05
US43325102P 2002-12-12 2002-12-12
US43350002P 2002-12-12 2002-12-12
US60/433,251 2002-12-12
US60/433,500 2002-12-12
US43331802P 2002-12-13 2002-12-13
US43331602P 2002-12-13 2002-12-13
US60/433,316 2002-12-13
US60/433,318 2002-12-13
US43623602P 2002-12-23 2002-12-23
US60/436,236 2002-12-23
US43791403P 2003-01-03 2003-01-03
US60/437,914 2003-01-03
US44082003P 2003-01-17 2003-01-17
US44082103P 2003-01-17 2003-01-17
US60/440,821 2003-01-17
US60/440,820 2003-01-17
US46370803P 2003-04-18 2003-04-18
US46371603P 2003-04-18 2003-04-18
US46370003P 2003-04-18 2003-04-18
US46373203P 2003-04-18 2003-04-18
US60/463,732 2003-04-18
US60/463,708 2003-04-18
US60/463,700 2003-04-18
US60/463,716 2003-04-18
US46720303P 2003-05-02 2003-05-02
US46723003P 2003-05-02 2003-05-02
US46720103P 2003-05-02 2003-05-02
US46719903P 2003-05-02 2003-05-02
US60/467,230 2003-05-02
US60/467,203 2003-05-02
US60/467,199 2003-05-02
US60/467,201 2003-05-02
US47133603P 2003-05-19 2003-05-19
US47130603P 2003-05-19 2003-05-19
US60/471,306 2003-05-19
US60/471,336 2003-05-19
US47243003P 2003-05-22 2003-05-22
US47242003P 2003-05-22 2003-05-22
US60/472,430 2003-05-22
US60/472,420 2003-05-22
US47664103P 2003-06-09 2003-06-09
US47660903P 2003-06-09 2003-06-09
US47663203P 2003-06-09 2003-06-09
US47662103P 2003-06-09 2003-06-09
US60/476,621 2003-06-09
US60/476,641 2003-06-09
US60/476,632 2003-06-09
US60/476,609 2003-06-09
US48522403P 2003-07-08 2003-07-08
US48521703P 2003-07-08 2003-07-08
US48521803P 2003-07-08 2003-07-08
US48522303P 2003-07-08 2003-07-08
US48535903P 2003-07-08 2003-07-08
US48532503P 2003-07-08 2003-07-08
US60/485,217 2003-07-08
US60/485,325 2003-07-08
US60/485,223 2003-07-08
US60/485,359 2003-07-08
US60/485,224 2003-07-08
US60/485,218 2003-07-08
US48648003P 2003-07-14 2003-07-14
US48644603P 2003-07-14 2003-07-14
US60/486,446 2003-07-14
US60/486,480 2003-07-14
US48696003P 2003-07-15 2003-07-15
US48689103P 2003-07-15 2003-07-15
US60/486,891 2003-07-15
US60/486,960 2003-07-15
US49334103P 2003-08-08 2003-08-08
US49357703P 2003-08-08 2003-08-08
US49337003P 2003-08-08 2003-08-08
US49357303P 2003-08-08 2003-08-08
US60/493,370 2003-08-08
US60/493,341 2003-08-08
US60/493,573 2003-08-08
US60/493,577 2003-08-08
PCT/US2003/033947 WO2004038003A2 (en) 2002-10-25 2003-10-24 Human polypeptides encoded by polynucleotides and methods of their use

Publications (2)

Publication Number Publication Date
AU2003298606A1 AU2003298606A1 (en) 2004-05-13
AU2003298606A8 true AU2003298606A8 (en) 2004-05-13

Family

ID=32180903

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003298606A Abandoned AU2003298606A1 (en) 2002-10-25 2003-10-24 Human polypeptides encoded by polynucleotides and methods of their use

Country Status (2)

Country Link
AU (1) AU2003298606A1 (en)
WO (1) WO2004038003A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825328B1 (en) 1998-07-20 2004-11-30 Stephen W. Scherer Lafora's disease gene
JP5576010B2 (en) 2003-08-04 2014-08-20 ザ・ホスピタル・フォー・シック・チルドレン Lafora disease gene
US7910722B2 (en) 2007-07-05 2011-03-22 Florida State University Research Foundation RNAi therapeutic for treatment of hepatitis C infection
GB201011819D0 (en) * 2010-07-14 2010-09-01 King S College London Neurodegenerative disorders
IL300591A (en) * 2016-05-11 2023-04-01 Amgen Inc Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors
CN109142729B (en) * 2018-06-14 2021-04-23 郑州大学第一附属医院 A kind of lung cancer marker anti-HMGB3 autoantibody and its application
JP7712207B2 (en) 2018-10-19 2025-07-23 ザ フランシス クリック インスティチュート リミティッド Novel cancer antigens and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225234B1 (en) * 2000-03-30 2001-05-01 Lam Research Corporation In situ and ex situ hardmask process for STI with oxide collar application

Also Published As

Publication number Publication date
WO2004038003A2 (en) 2004-05-06
AU2003298606A1 (en) 2004-05-13
WO2004038003A3 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
AU2003294217A8 (en) Human polypeptides encoded by polynucleotides and methods of their use
GB0212885D0 (en) Therapeutic epitopes and uses thereof
EP1576169A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003295343A8 (en) Uses of human zven proteins and polynucleotides
GB0615918D0 (en) Composition and its therapeutic use
AU2003298606A8 (en) Human polypeptides encoded by polynucleotides and methods of their use
GB0207410D0 (en) Compounds and their therapeutic use
AU2003217956A8 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
AU2003265787A8 (en) Methods of use for novel human polypeptides encoded by polynucleotides
EP1549671A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1569928A4 (en) Therapeutic compounds and methods
PL375356A1 (en) Claudin polypeptides, polynucleotides, and methods of making and use thereof
AU2003294236A8 (en) Methods of use for novel human polypeptides encoded by polynucleotides
AU2003284967A8 (en) Novel mouse polypeptides encoded by polynucleotides and methods of their use
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
AU2003304034A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1576168A4 (en) Therapeutic polypeptides nucleic acids encoding same and methods of use
AU2003270424A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1587829A4 (en) Human protooncogene and protein encoded therein
AU2003231152A8 (en) Novel essential fungal polynucleotides, polypeptides, and methods of use
AU2003223064A8 (en) Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
AU2002322404A8 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP1539807A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1513864A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1838728A4 (en) Human protooncogene and protein encoded therein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase